Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0175-2023

Drug recall · February 1, 2023

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator recall

Why: Short Fill

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Lots / codes

Lot #: 126451 Exp. 04/30/2023

Quantity
387,000 vials
Company
Nephron Sc Inc, West Columbia, SC
Distribution
Nationwide within the United States including Puerto Rico. Guatamala
Initiated
January 13, 2023 · Voluntary: Firm initiated
Classified
January 23, 2023
Reported
February 1, 2023
Ended
October 11, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Racepinephrine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.